Depending on the final trial results of DIGIT‐HF and DECISION, digitoxin could be an important treatment option, especially in patients with progressive renal dysfunction or kidney failure, for whom therapy and/or dose escalation with renin–angiotensin–aldosterone system inhibitors, ARNI, SGLT2i is problematic or no option. This evidence concerns the gene REN and hydrops fetalis.